We are live on ! Find out more
EDIT icon

Editas Medicine

264 hedge funds and large institutions have $591M invested in Editas Medicine in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 75 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 28

27% more call options, than puts

Call options by funds: $23.8M | Put options by funds: $18.6M

5% more capital invested

Capital invested by funds: $561M → $591M (+$30.3M)

3% more funds holding

Funds holding: 256264 (+8)

1.05% more ownership

Funds ownership: 69.17%70.22% (+1%)

3% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 75

Holders
264
Holders Change
+8
Holders Change %
+3.13%
% of All Funds
4.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
39
Increased
73
Reduced
75
Closed
28
Calls
$23.8M
Puts
$18.6M
Net Calls
+$5.13M
Net Calls Change
+$6.09M
Name Holding Trade Value Shares
Change
Change in
Stake
IWM
151
IHT Wealth Management
Illinois
$165K +$210K +13,458 New
MML Investors Services
152
MML Investors Services
Massachusetts
$165K +$210K +13,478 New
ProShare Advisors
153
ProShare Advisors
Maryland
$164K +$4.53K +291 +2%
VRS
154
Virginia Retirement Systems
Virginia
$157K +$199K +12,800 New
CM
155
Caption Management
Oklahoma
$154K +$132K +8,500 +213%
XT
156
XTX Topco
Cayman Islands
$146K +$186K +11,908 New
CIC
157
Cornercap Investment Counsel
Georgia
$143K
Public Employees Retirement Association of Colorado
158
Public Employees Retirement Association of Colorado
Colorado
$143K
Tudor Investment Corp
159
Tudor Investment Corp
Connecticut
$143K +$181K +11,646 New
DU
160
Delphia (USA)
Ontario, Canada
$136K -$75.2K -4,829 -30%
CC
161
Corton Capital
Ontario, Canada
$134K -$55.9K -3,585 -25%
Baird Financial Group
162
Baird Financial Group
Wisconsin
$133K +$5.83K +374 +4%
BRWA
163
B. Riley Wealth Advisors
Florida
$132K +$168K +10,760 New
Thrivent Financial for Lutherans
164
Thrivent Financial for Lutherans
Minnesota
$131K -$2.17M -139,211 -93%
LFM
165
Lumina Fund Management
New York
$129K
VEA
166
Virtus ETF Advisers
New York
$128K +$1.09K +70 +0.7%
HSA
167
Hussman Strategic Advisors
Maryland
$127K
BWP
168
BSW Wealth Partners
Colorado
$126K -$218 -14 -0.1%
Lazard Asset Management
169
Lazard Asset Management
New York
$116K +$13.6K +873 +10%
AB
170
Amalgamated Bank
New York
$108K +$1.34K +86 +1%
DCM
171
Dupont Capital Management
Delaware
$98K -$218K -13,987 -63%
Amundi
172
Amundi
France
$79K +$98.8K +6,343 New
Federated Hermes
173
Federated Hermes
Pennsylvania
$72K +$3.57K +229 +4%
NFSG
174
Newbridge Financial Services Group
Florida
$71K +$85.2K +5,470 +1,753%
AIP
175
Ameritas Investment Partners
Nebraska
$65K

EDIT Hedge Fund Activity: Q3 2022 in Review

264 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2022, worth a combined $591M — up 5.4% from $561M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new EDIT positions and 28 closed out — a net gain of 11 holders — while 73 added to existing stakes and 75 trimmed.

The largest buyer was Millennium Management, adding an estimated $27M. The largest seller was State Street, cutting an estimated $23.9M.

  • 264 institutional investors held Editas Medicine (EDIT) as of Q3 2022, up from 256 in Q2 2022.
  • Funds reported $591M of Editas Medicine stock for Q3 2022, up 5.4% quarter-over-quarter.
  • 39 funds opened new Editas Medicine positions in Q3 2022 and 28 closed out, a net change of +11 holders.
  • The largest Editas Medicine buyer in Q3 2022 was Millennium Management, an estimated $27M added.
  • The largest Editas Medicine seller in Q3 2022 was State Street, an estimated $23.9M sold.

Based on aggregated 13F filings for Q3 2022.